Goldman Sachs Maintains Buy on Ovintiv, Raises Price Target to $72

Benzinga · 10/27 16:56
Goldman Sachs analyst Neil Mehta maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $65 to $72.